DTE
49
16
MAC
53
5
MDT
59
4
DOV
48
2
CCL
68
6
MU
42
14
AN
49
2
T
32
2
SIG
52
5
UNH
42
6
MAR
57
3
EA
41
3
APH
53
3
MET
58
2
HCA
37
7
KSS
36
2
HD
43
8
AON
25
4
DG
14
6
VNO
46
6
DTE
49
16
MAC
53
5
MDT
59
4
DOV
48
2
CCL
68
6
MU
42
14
AN
49
2
T
32
2
SIG
52
5
UNH
42
6
MAR
57
3
EA
41
3
APH
53
3
MET
58
2
HCA
37
7
KSS
36
2
HD
43
8
AON
25
4
DG
14
6
VNO
46
6
Financhill
Back

Repligen Vs. Perspective Therapeutics Industry Stock Comparison

Sell
49

RGEN
Repligen

Last Price:
$144.48
Seasonality Move:
20.07%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Sell
49
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $144.47. The Score for RGEN is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $144.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.12 Buy
Relative Strength Index (14 RSI): 45.9 Sell
Chaikin Money Flow: -1218085 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (137.16 - 156) Sell
Bollinger Bands (100): (137.28 - 155.46) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.71 - 15.03) Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 153.13 Sell
20-day SMA: 150.36 Sell
50-day SMA: 143.82 Buy
200-day SMA: 151.49 Sell
8-day EMA: 150.36 Sell
20-day EMA: 149.32 Sell
50-day EMA: 146.14 Sell
200-day EMA: 150.57 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.97 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.02 Sell

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.19 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):